[CERO] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[CERO] CERo Therapeutics Holdings, Inc.
Announcement Date
28-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- 70.37%
YoY-
Quarter Report
CERO's Result
CERO's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 CAGR
Revenue 0 0 0 -
PBT -2,449 -1,393 -112 366.62%
Tax -0 45 0 -
NP -2,449 -1,421 -112 366.62%
Tax Rate - - - -
Total Cost 2,449 1,421 112 366.62%
Ratio Analysis
30/06/24 30/06/23 30/06/22 CAGR
NP Margin 0.00 0.00 0.00 -
Per Share
30/06/24 30/06/23 30/06/22 CAGR
EPS -0.15 -0.21 -0.00 -
EPS Diluted -0.15 -0.21 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.